Literature DB >> 23010649

Use of healthy volunteers drives clinical oncology drug development decision making.

M Iwamoto1, R Iannone, J A Wagner.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23010649     DOI： 10.1038/clpt.2012.157

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Dose-Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis.

Authors:  Yvonne Schuller; Christine Gispen-de Wied; Carla E M Hollak; Hubertus G M Leufkens; Violeta Stoyanova-Beninska
Journal:  J Clin Pharmacol       Date:  2018-09-07       Impact factor: 3.126

2.  Intrinsic and Extrinsic Pharmacokinetic Variability of Small Molecule Targeted Cancer Therapy.

Authors:  Eric Reyner; Bert Lum; Jing Jing; Matts Kagedal; Joseph A Ware; Leslie J Dickmann
Journal:  Clin Transl Sci       Date:  2019-12-12       Impact factor: 4.689

3.  First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug.

Authors:  Vincenzo Teneggi; Veronica Novotny-Diermayr; Lay Hoon Lee; Maryam Yasin; Pauline Yeo; Kantharaj Ethirajulu; Sylvia Bong Hwa Gan; Stephanie E Blanchard; Ranjani Nellore; Dhananjay N Umrani; Roberto Gomeni; Darren Lim Wan Teck; Greg Li; Qing Shu Lu; Yang Cao; Alex Matter
Journal:  Clin Transl Sci       Date:  2019-09-09       Impact factor: 4.689

4.  Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds.

Authors:  Igor Radanovic; Naomi Klarenbeek; Robert Rissmann; Geert Jan Groeneveld; Emilie M J van Brummelen; Matthijs Moerland; Jacobus J Bosch
Journal:  Front Oncol       Date:  2022-08-29       Impact factor: 5.738

Review 5.  Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development.

Authors:  Mariam A Ahmed; Chirag Patel; Nicole Drezner; Whitney Helms; Weiwei Tan; Daria Stypinski
Journal:  Clin Transl Sci       Date:  2019-10-31       Impact factor: 4.689
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.